Hall's most recent trade in Monster Beverage Corp. was a trade of 173 Deferred Stock Units done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monster Beverage | Tiffany M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 173 | 13,392 | - | - | Deferred Stock Units | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2025 | 22,180 | 700,370 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 03 Jul 2025 | 22,180 | 5,511,875 | - | 7.5 | 165,241 | Common Stock |
| SpringWorks Therapeutics Inc | C. Freda Lewis-Hall | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 29,983 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Lewis-Hall Freda C. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 24,727 | 0 (0%) | 0% | - | Common Stock | |
| SpringWorks Therapeutics Inc | C. Lewis-Hall Freda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 15,318 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Lewis-Hall Freda C. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 13,774 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Lewis-Hall C. Freda | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 12,216 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | C. Freda Lewis-Hall | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 7,464 | 0 | - | - | Stock Option (Right to Buy) | |
| CarGurus Inc - Ordinary Sh... | Hallowell Zachary Emerson | CEO, CarOffer | Sale of securities on an exchange or to another person at price $ 33.09 per share. | 01 Jul 2025 | 4,369 | 121,584 (0%) | 0% | 33.1 | 144,570 | Class A Common Stock |
| CarGurus Inc - Ordinary Sh... | Emerson Zachary Hallowell | CEO, CarOffer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.74 per share. | 01 Jul 2025 | 3,837 | 125,953 (0%) | 0% | 33.7 | 129,460 | Class A Common Stock |
| HubSpot Inc | Brian Halligan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 557.86 per share. | 01 Jul 2025 | 717 | 523,267 (1%) | 0% | 557.9 | 399,986 | Common Stock |
| Hancock Whitney Corp. | Ruena Hall Thompson | Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.40 per share. | 01 Jul 2025 | 626 | 21,240 (0%) | 0% | 57.4 | 35,932 | Common Stock |
| Gap, Inc. | Kathryn A. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 20,631 | 23,203 (0%) | 0% | 0 | Common Stock | |
| Gap, Inc. | Kathryn A. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 20,631 | 34,633 | - | - | Stock Units | |
| Gap, Inc. | Kathryn A. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 8,482 | 55,264 | - | - | Stock Units | |
| Gap, Inc. | Kathryn A. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 2,572 | 2,572 (0%) | 0% | 0 | Common Stock | |
| Gap, Inc. | Kathryn A. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 2,572 | 1,225 | - | - | Dividend Equivalent Rights | |
| Gap, Inc. | Kathryn A. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,381 | 3,798 | - | - | Dividend Equivalent Rights | |
| Wintrust Financial Corp. | Deborah L. Hall Lefevre | Director | Grant, award, or other acquisition of securities at price $ 112.46 per share. | 30 Jun 2025 | 519 | 14,860 (0%) | 0% | 112.5 | 58,367 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2025 | 23,060 | 722,550 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 26 Jun 2025 | 23,060 | 5,489,695 | - | 7.5 | 171,797 | Common Stock |
| Business First Bancshares ... | William G. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 1,016 | 1,016 | - | - | Restricted Stock Units | |
| Business First Bancshares ... | William G. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 767 | 767 | - | - | Stock Options (Right to Buy) | |
| Business First Bancshares ... | William G. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 767 | 767 | - | - | Stock Options (Right to Buy) | |
| Business First Bancshares ... | William G. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 511 | 511 | - | - | Stock Options (Right to Buy) | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 24 Jun 2025 | 21,300 | 5,466,635 | - | 7.5 | 158,685 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 21,300 | 745,610 | - | - | Employee Stock Option (Right to Buy) | |
| Immuneering Corp - Ordinar... | Brett Hall | CHIEF SCIENTIFIC OFFICER | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 20 Jun 2025 | 7,415 | 353,311 | - | 2.7 | 20,020 | Class A Common Stock |
| Immuneering Corp - Ordinar... | Brett Hall | CHIEF SCIENTIFIC OFFICER | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 20 Jun 2025 | 6,007 | 359,318 | - | 2.4 | 14,596 | Class A Common Stock |
| HubSpot Inc | Brian Halligan | Director | Sale of securities on an exchange or to another person at price $ 548.03 per share. | 17 Jun 2025 | 8,500 | 523,984 (1%) | 0% | 548.0 | 4,658,255 | Common Stock |
| Esperion Therapeutics Inc. | Benjamin Halladay | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 17 Jun 2025 | 7,229 | 474,473 (1%) | 0% | 1.2 | 8,328 | Common Stock |
| HubSpot Inc | Brian Halligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2025 | 6,955 | 1,694 | - | - | Stock Option (right to buy) | |
| HubSpot Inc | Brian Halligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.70 per share. | 17 Jun 2025 | 6,955 | 532,484 (1%) | 0% | 159.7 | 1,110,714 | Common Stock |
| Vera Bradley Inc | Robert J. Hall | Director, Member of a 10% owner group | Grant, award, or other acquisition of securities at price $ 2.07 per share. | 16 Jun 2025 | 37,846 | 2,314,713 (6%) | 0% | 2.1 | 78,341 | Common Stock |
| Vera Bradley Inc | Joan B. Hall | Member of a 10% owner group | Grant, award, or other acquisition of securities at price $ 2.07 per share. | 16 Jun 2025 | 37,846 | 2,314,713 (6%) | 0% | 2.1 | 78,341 | Common Stock |
| Vera Bradley Inc | Robert J. Hall | Director, Member of a 10% owner group | Grant, award, or other acquisition of securities at price $ 2.39 per share. | 16 Jun 2025 | 30,993 | 2,345,706 (6%) | 0% | 2.4 | 74,073 | Common Stock |
| Vera Bradley Inc | Joan B. Hall | Member of a 10% owner group | Grant, award, or other acquisition of securities at price $ 2.39 per share. | 16 Jun 2025 | 30,993 | 2,345,706 (6%) | 0% | 2.4 | 74,073 | Common Stock |
| Vera Bradley Inc | Robert J. Hall | Director, Member of a 10% owner group | Grant, award, or other acquisition of securities at price $ 2.19 per share. | 16 Jun 2025 | 23,674 | 2,369,380 (7%) | 0% | 2.2 | 51,846 | Common Stock |
| Vera Bradley Inc | Joan B. Hall | Member of a 10% owner group | Grant, award, or other acquisition of securities at price $ 2.19 per share. | 16 Jun 2025 | 23,674 | 2,369,380 (7%) | 0% | 2.2 | 51,846 | Common Stock |
| Vulcan Materials | O. B. Grayson Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2025 | 630 | 0 | - | - | Restricted Stock Units | |
| Vulcan Materials | O. B. Grayson Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2025 | 630 | 4,658 (0%) | 0% | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,568 | 20,568 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,372 | 15,372 | - | - | Stock Option (right to buy) | |
| Medallion Financial Corp. | Cynthia Hallenbeck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 13,172 | 73,745 | - | - | Restricted Stock Units | |
| Arcutis Biotherapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 7,609 | 26,435 (0%) | 0% | 0 | Common Stock | |
| Vaxcyte Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 10,216 | - | 0 | Common Stock | |
| Tetra Technologies, Inc. | Kurt Hallead | VP-Treasurer & IR | Purchase of securities on an exchange or from another person at price $ 3.39 per share. | 11 Jun 2025 | 72,633 | 148,764 (0%) | 0% | 3.4 | 246,226 | Common Stock |
| CytomX Therapeutics Inc | Halley E. Gilbert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| Monster Beverage | Tiffany M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 3,592 | 13,219 | - | - | Deferred Stock Units | |
| Monster Beverage | Tiffany M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 3,592 | 0 | - | - | Restricted Stock Units | |
| Monster Beverage | Tiffany M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 2,748 | 2,748 | - | - | Restricted Stock Units | |
| Ulta Beauty | Catherine A. Halligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 383 | 2,400 (0%) | 0% | 0 | Common Stock | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.20 per share. | 09 Jun 2025 | 8,000 | 5,445,335 | - | 58.2 | 465,637 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 09 Jun 2025 | 8,000 | 5,453,335 | - | 7.5 | 59,600 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 8,000 | 766,910 | - | - | Employee Stock Option (Right to Buy) | |
| TMC the metals company Inc | Andrew Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 66,508 | 359,267 | - | 0 | Common Shares | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 38,228 | 0 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 04 Jun 2025 | 38,228 | 0 | - | 10.2 | 391,455 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 38,228 | 38,228 | - | 4.3 | 164,380 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 38,227 | 38,227 | - | 4.3 | 164,376 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 38,227 | 38,228 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 38,227 | 76,455 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | David L. Hallal | Director | Sale of securities on an exchange or to another person at price $ 10.15 per share. | 04 Jun 2025 | 38,227 | 0 | - | 10.1 | 388,004 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 38,227 | 38,227 | - | 4.3 | 164,376 | Common Stock |
| ITeos Therapeutics Inc | David L. Hallal | Director | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 04 Jun 2025 | 38,227 | 0 | - | 10.1 | 384,946 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 02 Jun 2025 | 8,000 | 5,453,335 | - | 7.5 | 59,600 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 8,000 | 774,910 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.40 per share. | 02 Jun 2025 | 4,061 | 5,445,335 | - | 55.4 | 224,992 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.69 per share. | 02 Jun 2025 | 3,739 | 5,449,396 | - | 54.7 | 204,468 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.94 per share. | 02 Jun 2025 | 200 | 5,453,135 | - | 53.9 | 10,788 | Common Stock |
| HubSpot Inc | Brian Halligan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 592.02 per share. | 02 Jun 2025 | 158 | 525,529 (1%) | 0% | 592.0 | 93,539 | Common Stock |
| TMC the metals company Inc | Andrew Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 22,371 | 292,759 | - | 0 | Common Shares | |
| TMC the metals company Inc | Andrew Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 19,395 | 270,388 | - | 0 | Common Shares | |
| Gartner | Eugene A. Hall | Director, Chairman and CEO | Other type of transaction at price $ 414.57 per share. | 30 May 2025 | 14 | 1,170,257 (1%) | 0% | 414.6 | 5,804 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.21 per share. | 23 May 2025 | 18,069 | 5,445,335 | - | 55.2 | 997,580 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.74 per share. | 23 May 2025 | 13,131 | 5,463,404 | - | 54.7 | 718,847 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 23 May 2025 | 8,000 | 5,453,335 | - | 7.5 | 59,600 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2025 | 8,000 | 782,910 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.34 per share. | 23 May 2025 | 7,200 | 5,445,335 | - | 55.3 | 398,462 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.68 per share. | 23 May 2025 | 800 | 5,452,535 | - | 54.7 | 43,740 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.33 per share. | 21 May 2025 | 7,584 | 5,483,100 | - | 57.3 | 434,820 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.71 per share. | 21 May 2025 | 5,576 | 5,490,684 | - | 56.7 | 316,201 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.59 per share. | 21 May 2025 | 4,597 | 5,478,503 | - | 56.6 | 260,156 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.18 per share. | 21 May 2025 | 1,968 | 5,476,535 | - | 57.2 | 112,536 | Common Stock |
| HubSpot Inc | Brian Halligan | Director | Sale of securities on an exchange or to another person at price $ 645.54 per share. | 20 May 2025 | 8,500 | 525,687 (1%) | 0% | 645.5 | 5,487,090 | Common Stock |
| HubSpot Inc | Brian Halligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 5,602 | 8,649 | - | - | Stock Option (right to buy) | |
| HubSpot Inc | Brian Halligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.70 per share. | 20 May 2025 | 5,602 | 534,187 (1%) | 0% | 159.7 | 894,639 | Common Stock |
| HubSpot Inc | Brian Halligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 2,898 | 0 | - | - | Stock Option (right to buy) | |
| HubSpot Inc | Brian Halligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.15 per share. | 20 May 2025 | 2,898 | 528,585 (1%) | 0% | 112.2 | 325,011 | Common Stock |
| Origin Bancorp Inc | Martin Lance Hall | OBK COO, Origin Bank Pres&CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 1,514 | 3,028 | - | - | Restricted Stock Units | |
| Origin Bancorp Inc | Martin Lance Hall | OBK COO, Origin Bank Pres&CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2025 | 1,514 | 29,139 (0%) | 0% | - | Common Stock | |
| Origin Bancorp Inc | Martin Lance Hall | OBK COO, Origin Bank Pres&CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.89 per share. | 20 May 2025 | 628 | 28,511 (0%) | 0% | 33.9 | 21,283 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 55,255 | 5,500,590 | - | 0 | Common Stock | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.75 per share. | 19 May 2025 | 12,935 | 5,496,260 | - | 56.7 | 734,056 | Common Stock |
| Northern Trust | Aengus Hallinan | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 11,807 | 11,812 (0%) | 0% | 0 | Common Stock | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2025 | 8,605 | 77,485 | - | - | Restricted Share Units | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2025 | 8,605 | 5,509,195 | - | 0 | Common Stock | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share. | 19 May 2025 | 8,000 | 5,508,590 | - | 7.5 | 59,600 | Common Stock |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2025 | 8,000 | 790,910 | - | - | Employee Stock Option (Right to Buy) | |
| Intapp Inc | John Hall | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.24 per share. | 19 May 2025 | 6,300 | 5,500,590 | - | 57.2 | 360,586 | Common Stock |